We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

98 hedge funds and large institutions have $1.18B invested in IVERIC bio, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 13

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

54% more capital invested

Capital invested by funds: $768M → $1.18B (+$412M)

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

34% more funds holding

Funds holding: 73 → 98 (+25)

58% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $5.54M

Holders
98
Holders Change
+25
Holders Change %
+34.25%
% of All Funds
2.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
39
Increased
38
Reduced
15
Closed
13
Calls
$2.34M
Puts
$5.54M
Net Calls
-$3.2M
Net Calls Change
+$3.12M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$68.3M
2
JCG
JHL Capital Group
Illinois
+$55.8M
3
State Street
State Street
Massachusetts
+$13.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$12.5M
5
Morgan Stanley
Morgan Stanley
New York
+$9.24M

Top Sellers

1
CV
Clarus Ventures
Massachusetts
-$55M
2
RCM
RA Capital Management
Massachusetts
-$44.4M
3
CCM
Consonance Capital Management
New York
-$11.1M
4
ICAP
Independence Capital Asset Partners
Colorado
-$8.9M
5
BA
BlackRock Advisors
Delaware
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$292M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$209M +$68.3M +1,861,972 +61%
SHI
3
SV Health Investors
Massachusetts
$140M +$121M +3,308,695 New
JCG
4
JHL Capital Group
Illinois
$116M +$55.8M +1,520,000 +126%
CV
5
Clarus Ventures
Massachusetts
$65.8M -$55M -1,500,000 -49%
EAM
6
Eagle Asset Management
Florida
$57.4M +$1.9M +51,701 +4%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$50.5M +$7.22M +196,724 +20%
Vanguard Group
8
Vanguard Group
Pennsylvania
$37.2M +$12.5M +339,977 +63%
RCM
9
RA Capital Management
Massachusetts
$22.3M -$44.4M -1,209,915 -70%
State Street
10
State Street
Massachusetts
$21.3M +$13.6M +371,872 +283%
Morgan Stanley
11
Morgan Stanley
New York
$16.4M +$9.24M +251,825 +186%
PA
12
Perceptive Advisors
New York
$15.7M +$4.46M +121,469 +49%
BFA
13
BlackRock Fund Advisors
California
$12.9M +$2.6M +70,808 +30%
GPP
14
Great Point Partners
Connecticut
$10.6M +$9.18M +250,100 New
Goldman Sachs
15
Goldman Sachs
New York
$10.1M +$472K +12,870 +6%
Allianz Asset Management
16
Allianz Asset Management
Germany
$8.75M +$7.58M +206,715 New
BIT
17
BlackRock Institutional Trust
California
$6.72M +$2.27M +61,816 +64%
FWIA
18
Fort Washington Investment Advisors
Ohio
$5.64M +$1.02M +27,699 +26%
Barclays
19
Barclays
United Kingdom
$5.55M +$4.84M +131,858 +36,225%
Northern Trust
20
Northern Trust
Illinois
$5.25M +$395K +10,770 +10%
HLA
21
Hamilton Lane Advisors
Pennsylvania
$3.91M +$3.39M +92,372 New
HCM
22
Highbridge Capital Management
New York
$3.74M +$3.25M +88,468 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$3.48M +$1.39M +38,003 +86%
AP
24
AlpInvest Partners
Netherlands
$3.47M +$3.01M +82,046 New
SOMRS
25
State of Michigan Retirement System
Michigan
$3.47M +$3.01M +82,046 New
1
2 3 4 5

ISEE Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2014, worth a combined $1.18B — up 54% from $768M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 13 closed out — a net gain of 26 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $68.3M. The largest seller was Clarus Ventures, cutting an estimated $55M.

  • 98 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2014, up from 73 in Q1 2014.
  • Funds reported $1.18B of IVERIC bio, Inc. Common Stock stock for Q2 2014, up 54% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2014 and 13 closed out, a net change of +26 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2014 was Fidelity Investments, an estimated $68.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2014 was Clarus Ventures, an estimated $55M sold.

Based on aggregated 13F filings for Q2 2014.